Powder: -20°C for 3 years | In solvent: -80°C for 1 year
BMS-641988 is a novel nonsteroidal androgen receptor antagonist for the treatment of prostate cancer.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 163.00 | |
5 mg | In stock | $ 400.00 | |
10 mg | In stock | $ 600.00 | |
25 mg | In stock | $ 959.00 | |
50 mg | In stock | $ 1,280.00 | |
100 mg | In stock | $ 1,750.00 |
Description | BMS-641988 is a novel nonsteroidal androgen receptor antagonist for the treatment of prostate cancer. |
In vivo | Sixty-one men with CRPC were treated with daily BMS-641988 (5 to 150 mg). Seventeen of 23 evaluable patients (74%) exhibited stable disease on imaging (median 15 weeks; range 8-32), and 10 of 61 patients (16%) achieved a ≥ 30% decline in levels of prostate-specific antigen (PSA).[1] |
Molecular Weight | 471.45 |
Formula | C20H20F3N3O5S |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
BMS-641988 Endocrinology/Hormones Androgen Receptor inhibitor inhibit